Summary and Conclusion
The coprocessed superdisintegrant proved to be superior to the physical blend in terms of flow due to size enlargement. Furthermore, the coprocessed superdisintegrant displayed superiority in terms of crushing strength, disintegration time, and drug dissolution. The advantages of the proposed method are easy adaptability in industry and the possibility of bypassing the existing patents in the ereas of quick disintegration and dissolution.
KeyWords: Croscarmellose sodium, crospovidone, coprocessing by dry granulation, dissolution enhancement, ibuprofen
Full Text
The Full Text of this article is available as a PDF (205.1 KB).
References
- 1.Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986. pp. 293–345. [Google Scholar]
- 2.Shangraw R, Mitrevej A, Shah M. A new era of tablet disintegrants. Pharm Technol. 1980;4:49–57. [Google Scholar]
- 3.Zhao N, Augusburger L. The influence of swelling capacity of superdisintegrants in different pH media on dissolution of hydrochlorthiazide from directly compressed tablets. AAPS PharmSciTech. 2005;6:E120–E126. doi: 10.1208/pt060119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pharmaceutical Products. Intermational Specialty Products Web site. Available at: http://www.ispcorp.com/products/pharma/content/brochure/polycros. Accessed May 10, 2006.
- 5.Biopolymer-Pharmaceuticals-Disintegrants. FMC Corporation Web site. Available at: http://www.fmcbiopolymer.com/Pharmaceuticals/Disintegrants/tabid/503/Default.aspx. Accessed February 7, 2007.
- 6.Pharmacopeia US.USP 29-NF 24. Rockville, MD: USP; 2005.
- 7.Gohel MC, Patel SD, Shah NK, Jani GK. Evaluation of synthesized cross-linked tragacanth as a potential disintegrant. Indian J Pharm Sci. 2007;59:113–118. [Google Scholar]
- 8.Thibert R, Hancock BC. Direct visualization of superdisintegrant hydration using environmental scanning electron microscopy. J Pharm Sci. 2007;85:1255–1258. doi: 10.1021/js960188d. [DOI] [PubMed] [Google Scholar]
- 9.Rudnic E. Oral solid dosage forms. In: Gennaro AR, editor. Remington: The Science and Practice of Pharmacy Volume II. 19th ed. Easton, PA: Mack Publishing Company; 1995. pp. 1615–1649. [Google Scholar]
- 10.Alderborn G, Nystrom C. Pharmaceutical Powder Compaction Technology. New York, NY: Marcel Dekker; 2007. [Google Scholar]
- 11.He X, Kibbe AH. Crospovidone. In: Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003. pp. 108–111. [Google Scholar]
- 12.Gohel MC, Jogani PD, Bariya SH. Development of agglomerated directly compressible diluents consisting of brittle and ductile materials. Pharm Dev Technol. 2003;8:143–151. doi: 10.1081/PDT-120018481. [DOI] [PubMed] [Google Scholar]
- 13.Marshall PV, Pope DG, Carstensen JT. Methods for the assessment of the stability of tablet disintegrants. J Pharm Sci. 1991;80:899–903. doi: 10.1002/jps.2600800920. [DOI] [PubMed] [Google Scholar]
- 14.Gordon MS, Rudraraju VS, Kaushik D, Chhowhan ZT. Effect of mode of superdisintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci. 1993;82:220–226. doi: 10.1002/jps.2600820222. [DOI] [PubMed] [Google Scholar]
- 15.Mishra DN, Bindal M, Singh SK, Vijaya Kumar GV. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull (Tokyo) 2006;54:99–102. doi: 10.1248/cpb.54.99. [DOI] [PubMed] [Google Scholar]